Skip to main content

Table 1 Baseline mice and tumor characteristics in mice receiving chemotherapy only

From: Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model

 

FFX X1 (n = 6)

FFX X2 (n = 30)

GEM/AB X1 (n = 6)

GEM/AB X2 (n = 6)

Control (n = 28)

Age

16.9 (10.9–26.1)

24.8 (21.7–26.9)

21.3 (16.1–25.2)

14.3 (9.1–23.5)

21.7 (17.4–25.6)

Tumor Diameter at Dx

9.3 (7.1–10.2)

6.7 (6.2–7.4)

7.1 (5.5–8.0)

4.8 (4.0–6.9)

7.0 (5.0–8.0)

Weight at Dx

23.6 (20.5–28.1)

25.2 (23.4–26.8)

25.3 (22.0–28.4)

24.5 (21.1–28.9)

24.3 (23.2–25.7)

Sex

 Female

3 (50.0)

15 (50.0)

2 (33.3)

2 (33.3)

10 (35.7)

 Male

3 (50.0)

15 (50.0)

4 (66.7)

4 (66.7)

18 (64.3)

Tumor Location

 Head

0 (0)

7 (23.3)

4 (66.7)

2 (33.3)

13 (46.4)

 Body

3 (50.0)

10 (33.3)

2 (33.3)

1 (16.7)

10 (35.7)

 Tail

2 (33.3)

13 (43.3)

0 (0)

3 (50.0)

5 (17.9)

 Neck

1 (16.7)

0 (0)

0 (0)

0 (0)

0 (0)